Drug Profile
VB 9450
Alternative Names: antibacterial therapeutics - Vyome Therapeutics; DARTSTM Therapeutics; DARTSTM antibiotics - Vyome TherapeuticsLatest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator Vyome Biosciences
- Developer Vyome Therapeutics
- Class Anti-infectives; Antiacnes
- Mechanism of Action Bacterial growth inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Jul 2023 No recent reports of development identified for preclinical development in Bacterial-infections in USA
- 27 Jun 2019 Discontinued - Preclinical for Bacterial infections in India (unspecified route) (Vyome Therapeutics pipeline June 2019)
- 27 Jun 2019 Preclinical trials in Bacterial infections in USA (unspecified route) (Vyome Therapeutics pipeline June 2019)